You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Details for Patent: 9,339,036


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,339,036 protect, and when does it expire?

Patent 9,339,036 protects DEFENCATH and is included in one NDA.

This patent has thirteen patent family members in eight countries.

Summary for Patent: 9,339,036
Title:Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
Abstract:The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, and (B) heparin at a low concentration.
Inventor(s):Prosl Frank R.
Assignee:ND Partners, LLC
Application Number:US14034877
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,339,036: A Comprehensive Review

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article delves into the specifics of United States Patent 9,339,036, exploring its claims, technological context, and the broader patent landscape.

Patent Overview

United States Patent 9,339,036, hereafter referred to as the '036 patent, is part of a family of patents related to image sensors and personal digital assistant devices. This patent is a continuation of earlier patents in the same family, indicating a complex and interconnected set of inventions[2].

Claims and Scope

The '036 patent, like its related patents, claims priority from a single application and is part of a series of continuations-in-part. The claims within this patent are critical for defining its scope and determining its validity.

Claim Structure

Patent claims are the heart of any patent, defining what is protected by the patent. For the '036 patent, the claims would typically include independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the invention further by adding additional limitations[5].

Claim Validity

The validity of the '036 patent's claims was challenged in the context of obviousness-type double patenting (ODP). The U.S. Court of Appeals for the Federal Circuit found that the claims of the '036 patent, as well as its related patents, were unpatentable over earlier claims in the same family. This highlights the importance of ensuring that each patent in a family does not overlap excessively with its predecessors[2].

Technological Context

The '036 patent falls within the broader category of electrical engineering and information and communication technologies (ICT). This area has seen significant growth in patent filings over the past two decades, driven by advancements in digital technologies.

Technology Areas

The USPTO classifies patents into 35 technical fields as defined by the World Intellectual Property Organization (WIPO). The '036 patent would be classified under fields related to electrical engineering, specifically within the areas of computer technology and digital communication. These fields have experienced substantial increases in patent activity, reflecting the rapid innovation in these sectors[1].

Patent Landscape Analysis

To understand the strategic significance of the '036 patent, it is essential to conduct a patent landscape analysis.

Patent Portfolio

A patent landscape analysis involves mapping the patent portfolio of a company or inventor against the broader technological landscape. For the '036 patent, this would involve identifying other patents in the same family and their technological classifications. This analysis can reveal trends, such as the focus on image sensors and personal digital assistant devices, and how these patents fit into the overall strategy of the patent holder[3].

Time-Slicing and Trend Analysis

Time-slicing, which involves analyzing patent activity over different time periods, can provide insights into the evolution of a technology area. For the '036 patent, time-slicing could show how the focus on image sensors and related technologies has changed over the years. This can help in identifying whether the technology is being abandoned or if it remains a key area of innovation[3].

Strategic Insights

Competitive Analysis

A patent landscape analysis can also reveal competitive insights. By comparing the patent portfolio of the '036 patent holder with those of competitors, one can identify areas of strength and weakness. This can inform strategic decisions about where to focus research and development efforts and how to protect intellectual property[3].

Resource Allocation

The analysis can also show how resources are allocated within a company. For instance, if a company has a significant number of patents in a particular area, it may indicate a major focus on that technology. This can be crucial for understanding the market position and future directions of the company[3].

Legal and Policy Considerations

Small Claims Patent Court

The discussion around the '036 patent and its validity also touches on broader legal and policy issues. For example, the concept of a small claims patent court, which has been studied by the Administrative Conference of the United States (ACUS), could impact how patent disputes are resolved. Such a court could provide a more streamlined and cost-effective way to handle patent infringement cases, which could be relevant for patents like the '036 patent that are part of complex litigation[4].

Patent Quality and Scope

The debate over patent quality and scope is also relevant. Metrics such as independent claim length and independent claim count can be used to measure patent scope and quality. Narrower claims are often associated with a higher probability of grant and shorter examination processes, which can be important considerations for inventors and patent holders[5].

Key Takeaways

  • Patent Claims and Validity: The '036 patent's claims are critical for its validity, and challenges such as ODP must be carefully managed.
  • Technological Context: The patent falls within the electrical engineering and ICT sectors, which are highly active in terms of patent filings.
  • Patent Landscape Analysis: This analysis is essential for understanding the strategic position of the patent and identifying trends and competitors.
  • Resource Allocation: The patent portfolio can reveal how a company allocates its resources and focuses its innovation efforts.
  • Legal and Policy Considerations: Broader legal issues, such as the potential for a small claims patent court and debates over patent quality, can impact the management and litigation of patents like the '036 patent.

FAQs

What is the '036 patent related to?

The '036 patent is related to image sensors and personal digital assistant devices, part of a family of patents with interconnected claims.

Why is the '036 patent important in the context of ODP?

The '036 patent was found to be unpatentable over earlier claims in the same family, highlighting the importance of managing ODP in patent families.

How does the '036 patent fit into the broader patent landscape?

The '036 patent is part of the electrical engineering and ICT sectors, which have seen significant growth in patent filings. A patent landscape analysis can provide insights into its strategic significance.

What are the implications of narrower claims in patent applications?

Narrower claims are associated with a higher probability of grant and shorter examination processes, which can be beneficial for inventors and patent holders.

How might a small claims patent court impact patent litigation?

A small claims patent court could provide a more streamlined and cost-effective way to handle patent infringement cases, potentially simplifying the litigation process for patents like the '036 patent.

Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  2. In re Cellect - United States Court of Appeals for the Federal Circuit.
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP.
  4. U.S. Patent Small Claims Court - Administrative Conference of the United States.
  5. Patent Claims and Patent Scope - SSRN.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,339,036

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cormedix DEFENCATH heparin sodium; taurolidine SOLUTION;N/A 214520-001 Nov 15, 2023 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
Cormedix DEFENCATH heparin sodium; taurolidine SOLUTION;N/A 214520-002 Nov 15, 2023 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,339,036

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 101094679 ⤷  Subscribe
China 103083353 ⤷  Subscribe
Germany 202005022124 ⤷  Subscribe
Denmark 1814562 ⤷  Subscribe
European Patent Office 1814562 ⤷  Subscribe
European Patent Office 2742945 ⤷  Subscribe
Spain 2456946 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.